Jardiance, known generically as empagliflozin, is a medication primarily used to manage type 2 diabetes. It belongs to a class of drugs called SGLT2 inhibitors, which help lower blood sugar levels by preventing the kidneys from reabsorbing glucose back into the bloodstream.
What Are Generic Names?
The term generic names for Jardiance refers to the non-brand name of the drug that can be used interchangeably with its brand name. These names often reflect the active ingredient in the medication without the branding associated with specific manufacturers.
Key Points About Empagliflozin
- Mechanism of Action: Empagliflozin works by inhibiting the sodium-glucose transporter 2 (SGLT2) in the kidneys, leading to increased glucose excretion and improved glycemic control.
- Indications: Primarily prescribed for managing type 2 diabetes, it may also reduce the risk of cardiovascular death in patients with heart disease.
- Dosage Forms: Available in oral tablet form, commonly in doses of 10 mg and 25 generic names for jardiance mg.
Common Generic Alternatives
While empagliflozin is the primary generic name for Jardiance, it is important to note that there are similar medications within the same drug class. Some other options include:
- Dapagliflozin (Farxiga)
- Canagliflozin (Invokana)
- Ertugliflozin (Steglatro)
FAQs About Jardiance and Its Generic Name
- Is empagliflozin available in generic form?
- As of now, empagliflozin has not yet gone off patent, so it is mainly available under the brand name Jardiance.
- Are there any side effects associated with empagliflozin?
- Common side effects include urinary tract infections, genital yeast infections, and dehydration. It’s essential to consult a healthcare provider for comprehensive information.
- Where can I find more information about empagliflozin?
- For further details, you may visit Jardiance Official Site.
Understanding the generic names for Jardiance and their implications can help patients make informed decisions about their diabetes management. Always consult with a healthcare professional when considering treatment options.